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Background:  Diabetes mellitus (DM) is strongly associated with high residual platelet reactivity (HRPR), contributing to increased cardiovascular 
risk among patients treated with clopidogrel. Chronic kidney disease (CKD) is a frequent complication of DM and patients with both CKD and 
DM are at particularly high risk for adverse events. Whether or not this enhanced risk reflects a synergistic effect of both DM and CKD on platelet 
aggregation is unknown.
Methods:  We studied 185 patients on chronic clopidogrel (75 mg/day) who underwent platelet function testing at the time of coronary 
angiography. HRPR to adenosine disphosphate (ADP) was assessed using the VerifyNow P2Y12 Analyzer and expressed as P2Y12 Reaction Units 
(PRU). HRPR was defined as PRU values ≥ 235. CKD was defined as an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2.
Results:  The frequencies of HRPR among those without CKD or DM (n=75), CKD alone (n=25), DM alone (n=53) and both CKD and DM (n=32) 
were 33%, 52%, 54% and 63%, respectively (p = .02). Compared to those without CKD or DM, the multivariable adjusted odds ratios (OR) for 
HRPR associated with CKD alone, DM alone and both CKD and DM was 1.9 (95% CI: 0.6-5.7), 1.8 (95% CI: 0.8-4.3), and 2.9 (95% CI: 1.1-7.9), 
respectively (Table).
Conclusion: Patients with both CKD and DM demonstrate enhanced RPR to ADP compared to those with CKD or DM alone. Further investigation to 
identify associated adverse events and need for other treatments in this high risk subset is warranted.
Impact of Diabetes Mellitus and Chronic Kidney Disease on High Residual Platelet Reactivity
CKD alone DM alone CKD + DM
Unadjusted 2.2 (0.9 - 5.4) 2.4 (1.1 - 4.9) 3.3 (1.4 - 7.9)
Age, Race, Sex adjusted 2.3 (0.9 - 6.3) 1.8 (0.8 - 3.9) 3.5 (1.3 - 8.9)
Multivariable adjusted** 1.9 (0.6 - 5.7) 1.8 (0.8 - 4.3) 2.9 (1.1 - 7.9)
